C9orf72 suppresses systemic and neural inflammation induced by gut bacteria

被引:0
作者
Aaron Burberry
Michael F. Wells
Francesco Limone
Alexander Couto
Kevin S. Smith
James Keaney
Gaëlle Gillet
Nick van Gastel
Jin-Yuan Wang
Olli Pietilainen
Menglu Qian
Pierce Eggan
Christopher Cantrell
Joanie Mok
Irena Kadiu
David T. Scadden
Kevin Eggan
机构
[1] Harvard University,Harvard Stem Cell Institute, Department of Stem Cell and Regenerative Biology
[2] Broad Institute of MIT and Harvard,Stanley Center for Psychiatric Research
[3] Royal Netherlands Academy of Arts and Sciences,Hubrecht Institute for Developmental Biology and Stem Cell Research
[4] UCB Biopharma SPRL,Neuroscience Therapeutic Area, New Medicines
[5] Massachusetts General Hospital,Center for Regenerative Medicine
[6] Harvard University,Department of Molecular and Cellular Biology
来源
Nature | 2020年 / 582卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
A hexanucleotide-repeat expansion in C9ORF72 is the most common genetic variant that contributes to amyotrophic lateral sclerosis and frontotemporal dementia1,2. The C9ORF72 mutation acts through gain- and loss-of-function mechanisms to induce pathways that are implicated in neural degeneration3–9. The expansion is transcribed into a long repetitive RNA, which negatively sequesters RNA-binding proteins5 before its non-canonical translation into neural-toxic dipeptide proteins3,4. The failure of RNA polymerase to read through the mutation also reduces the abundance of the endogenous C9ORF72 gene product, which functions in endolysosomal pathways and suppresses systemic and neural inflammation6–9. Notably, the effects of the repeat expansion act with incomplete penetrance in families with a high prevalence of amyotrophic lateral sclerosis or frontotemporal dementia, indicating that either genetic or environmental factors modify the risk of disease for each individual. Identifying disease modifiers is of considerable translational interest, as it could suggest strategies to diminish the risk of developing amyotrophic lateral sclerosis or frontotemporal dementia, or to slow progression. Here we report that an environment with reduced abundance of immune-stimulating bacteria10,11 protects C9orf72-mutant mice from premature mortality and significantly ameliorates their underlying systemic inflammation and autoimmunity. Consistent with C9orf72 functioning to prevent microbiota from inducing a pathological inflammatory response, we found that reducing the microbial burden in mutant mice with broad spectrum antibiotics—as well as transplanting gut microflora from a protective environment—attenuated inflammatory phenotypes, even after their onset. Our studies provide further evidence that the microbial composition of our gut has an important role in brain health and can interact in surprising ways with well-known genetic risk factors for disorders of the nervous system.
引用
收藏
页码:89 / 94
页数:5
相关论文
共 56 条
  • [1] DeJesus-Hernandez M(2011)Expanded GGGGCC hexanucleotide repeat in noncoding region of Neuron 72 245-256
  • [2] Majounie E(2012) causes chromosome 9p-linked FTD and ALS Lancet Neurol. 11 323-330
  • [3] Mori K(2013)Frequency of the Science 339 1335-1338
  • [4] Ash PEA(2013) hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study Neuron 77 639-646
  • [5] Donnelly CJ(2013)The Neuron 80 415-428
  • [6] O’Rourke JG(2016) GGGGCC repeat is translated into aggregating dipeptide-repeat proteins in FTLD/ALS Science 351 1324-1329
  • [7] Burberry A(2016)Unconventional translation of Sci. Transl. Med. 8 347ra93-325
  • [8] Nassif M(2017) GGGGCC expansion generates insoluble polypeptides specific to c9FTD/ALS Front. Neurosci. 11 442-158
  • [9] Woehlbier U(2018)RNA toxicity from the ALS/FTD Nat. Med. 24 313-546
  • [10] Manque PA(2004) expansion is mitigated by antisense intervention Comp. Med. 54 128-550